Exploring Carbomer's Potential: Applications in Oral Mucoadhesive Controlled Drug Delivery Systems

In modern pharmaceutics, the pursuit of efficient controlled drug delivery systems has gained immense attention. These systems not only improve therapeutic outcomes by maintaining steady plasma drug levels but also reduce dosing frequency, minimize toxicity, and enhance patient compliance. A representative of these systems is the oral mucosal adhesive controlled drug delivery system. Among the wide range of excipients used for developing controlled drug delivery systems, carbomers (cross-linked polyacrylic acid polymers) have emerged as particularly valuable. Their physicochemical properties, ability to form mucoadhesive gels, and adaptability in modulating drug release make them essential candidates for oral mucoadhesive controlled drug delivery ^[1].

Physicochemical Properties of Carbomers

Carbomers are high-molecular weight, cross-linked carboxyvinyl polymers. Commercially available grades, such as Carbomer 934P, 971P, and 974P, differ in molecular weight and degree of cross-linking. These polymers contain 56-58% carboxylic acid groups, enabling them to swell extensively in aqueous environments. Upon neutralization, carbomers undergo uncoiling due to electrostatic repulsion among carboxyl groups, creating a viscous gel network capable of controlling drug diffusion. Their polyanionic nature, high swelling capacity, and stability over a broad pH range contribute to their success as mucoadhesive and controlled-release excipients. Carbomers also exhibit high glass transition temperatures (~100 °C), low bulk density, and the ability to form hydrogen bonds—critical factors for mucoadhesion.

Explore Our Carbomer Products

Typical products include:

• Carbomer 971P
• Carbomer 934P
• Carbomer 974P
• Carbomer 956
• …

Applications in Oral Mucoadhesive Controlled Drug Delivery Systems

The application of carbomers in oral mucoadhesive controlled drug delivery systems spans a wide range of dosage forms, each designed to optimize drug release, improve patient compliance, and enhance therapeutic efficacy.

• Mucoadhesive Tablets: Carbomer-based mucoadhesive tablets are one of the most extensively investigated systems. These formulations adhere to the buccal or gastrointestinal mucosa, providing prolonged contact time and sustained drug release. Examples include diclofenac sodium and indomethacin tablets formulated with polycarbophil, which not only provided controlled release but also reduced gastric irritation compared to conventional forms.
• Buccal and Sublingual Patches: Carbomer-based buccal patches offer targeted delivery, especially useful for drugs with poor oral bioavailability due to first-pass metabolism. For examples, benzydamine hydrochloride and lidocaine hydrochloride patches prepared with polycarbophil and carbomer 940 demonstrated effective adhesion, prolonged residence time, and localized drug delivery for oral inflammation and pain relief. Codeine phosphate sublingual tablets using carbomer blends enabled rapid onset while ensuring mucoadhesion for sustained systemic absorption.
• Lozenges and Chewable Dosage Forms: Carbomer-containing lozenges, such as those incorporating cetylpyridinium chlorides, improved local drug retention in the oral cavity. The mucoadhesive nature prolongs drug contact with mucosal tissues, making lozenges suitable for antiseptics, anesthetics, and anti-inflammatory drugs.
• Oral Suspensions and Liquids: Carbomers are effective in stabilizing suspensions while imparting controlled-release properties. For instance, hydrochlorothiazide suspensions with Carbomer 934P showed prolonged antihypertensive effects while maintaining good stability. Their high viscosity and stability under thermal variations make carbomers ideal excipients for liquid formulations.

Mechanisms of Mucoadhesion

Mucoadhesion refers to the attachment of a polymer to the mucosal layer, enabling prolonged drug residence at a specific site. For carbomers, several mechanisms contribute:

• Hydrogen Bonding: Carboxyl groups form strong hydrogen bonds with hydroxyl or amine groups in mucin.
• Chain Interpenetration: Relaxation of polymer chains allows entanglement with mucin glycoproteins.
• Water Movement: Partially hydrated carbomers absorb water from mucus, strengthening adhesion.
• Electrostatic Interactions: Though less dominant, ionic interactions may supplement hydrogen bonding.

These mechanisms result in robust adhesion, making carbomers ideal for buccal, sublingual, and gastrointestinal drug delivery.

Advantages of Carbomers in Oral Mucoadhesive Controlled Drug Delivery Systems

• Mucoadhesion: Carbomers interact with mucin glycoproteins, allowing dosage forms to remain localized at absorption sites, thus increasing bioavailability.
• Sustained Release: Even at low concentrations, carbomers provide prolonged release, approaching zero-order kinetics in certain formulations.
• Mucosal Protection: Carbomers form thick barriers, protecting mucosa against irritants and reducing ulcerogenic potential of drugs such as NSAIDs.
• Versatility: They function as disintegrants, matrix formers, and compression aids in tablet formulations.
• Biological Compatibility: Carbomers are physiologically inert, non-absorbable, and non-toxic.

Explore More: Carbomers in Peptide and Protein Delivery

Oral delivery of peptides and proteins presents certain challenges due to enzymatic degradation and poor permeability. Carbomers contribute significantly in this area by:

• Enzyme Inhibition: Carbomers chelate calcium ions, inhibiting proteolytic enzymes such as trypsin and chymotrypsin.
• Barrier Protection: They create localized acidic microenvironments, shielding peptides from enzymatic attack.
• Permeability Enhancement: Carbomers loosen tight junctions, facilitating paracellular transport of hydrophilic molecules.

Studies have shown carbomer-based systems to improve bioavailability of insulin, desmopressin, calcitonin, and vasopressin analogues. Notably, freeze-dried sodium salts of carbomers (e.g., FD934) further enhance intestinal absorption of peptides.

Explore Our Offering

Carbomers are among the most versatile excipients for developing oral mucoadhesive controlled drug delivery systems. Their unique swelling, mucoadhesive, and drug release characteristics make them invaluable in designing formulations ranging from small-molecule sustained-release tablets to advanced peptide delivery systems.

At our company, we provide a comprehensive portfolio of high-quality pharmaceutical-grade carbomers that meet international standards such as USP, EP, and JP. Our product line covers multiple grades of carbomers, which enable formulators to fine-tune drug release profiles and mucoadhesive strength. Our carbomer products are widely used in academic research, pharmaceutical R&D, and industrial-scale manufacturing worldwide. Whether the goal is to enhance bioavailability of a small molecule, improve patient adherence through reduced dosing frequency, or enable non-invasive delivery of peptides and proteins, our solutions provide the reliability and performance required to achieve these objectives.

Please kindly note that our services are for research use only.